Real-World study to assess iloprost in Lung-Related hypertension

NCT ID NCT07478094

First seen Mar 17, 2026 · Last updated May 15, 2026 · Updated 14 times

Summary

This study looks at how patients with pulmonary hypertension caused by chronic lung diseases, like interstitial lung disease, do over time when treated with inhaled iloprost in everyday medical practice. Researchers will review medical records of about 50 adults to see if their risk level improves, stays the same, or gets worse. The goal is to gather real-world evidence on this treatment's effectiveness and safety in this specific group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION DUE TO LUNG DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo

    São Paulo, São Paulo, 05403-900, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.